NASDAQ: PYXSPyxis Oncology Inc Stock Ownership - Who owns Pyxis Oncology?
Insider buying vs selling
Have Pyxis Oncology Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when PYXS insiders and whales buy or sell their stock.
PYXS Shareholders
What type of owners hold Pyxis Oncology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pfizer Inc | 11.30% | 7,032,770 | $10.83M | Insider |
| Pfizer Inc | 11.30% | 7,032,770 | $10.83M | Institution |
| Laurion Capital Management LP | 7.70% | 4,796,479 | $7.39M | Institution |
| Gordonmd Global Investments LP | 6.62% | 4,121,870 | $6.35M | Institution |
| Barclays PLC | 5.59% | 3,477,975 | $5.36M | Insider |
| Pamela Ann Connealy | 5.50% | 3,425,179 | $5.27M | Insider |
| Bayer World Investments Bv | 4.40% | 2,742,338 | $4.22M | Insider |
| Lara Sullivan | 3.86% | 2,403,882 | $3.70M | Insider |
| Vanguard Group Inc | 3.75% | 2,335,768 | $3.60M | Institution |
| Cormorant Asset Management LP | 1.80% | 1,118,854 | $1.72M | Insider |
PYXS vs Biotech Stocks
Pyxis Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.